Human IgG subclass antibodies to the 19 kilodalton carboxy terminal fragment of Plasmodium Falciparum merozoite surface protein 1 (MSP119) and predominance of the MAD20 allelic type of MSP1 in Uganda

East African Medical Journal

Volumn 77, Issue 4, 2000, Pages 189-193

  Apio, B ^a   Nalunkuma, A ^b   Okello, D ^c   Riley, E ^d   Egwang, T G ^b  

^a Biochemistry and Chemistry   (Uganda)

^b Med Biotech Laboratories Uganda   (Uganda)

^c MAKERERE UNIVERSITY MEDICAL SCHOOL   (Uganda)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; MEROZOITE SURFACE PROTEIN 1; PARASITE ANTIGEN; PEPTIDE FRAGMENT; PROTOZOON ANTIBODY;

ANIMAL; ARTICLE; BLOOD; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; HUMAN; IMMUNOLOGY; MALARIA FALCIPARUM; MOLECULAR WEIGHT; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; UGANDA;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE FREQUENCY; HUMANS; IMMUNOGLOBULIN G; MALARIA, FALCIPARUM; MEROZOITE SURFACE PROTEIN 1; MOLECULAR WEIGHT; PEPTIDE FRAGMENTS; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SEROEPIDEMIOLOGIC STUDIES; UGANDA;

EID: 0034343078     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Howard. R.J. and Pasloske. B.L. Target antigens for asexual malaria vaccine development. Parasitol. Today 1991; 9: 369-374
2. Chappel, J A and Holder, A A. Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognise the first growth factor-like domain of merozoite surface protein I Mol. Biochem. Parasit. 1993; 60: 303-312.
3. Diggs, C. L., Ballou. W. R. and Miller. L H The major surface protein as a malaria vacant target. Parasitol Today 1993; 9: 300-302.
4. Etlinger. H. M , Caspers. P., Matile. H., Schoenfeld. H J.. Stueber. D. and Takacs. B Ability of recombinant or native proteins to protect monkeys against heterologuos challenge with Plasmodium falciparum Infect. Immun. 1991: 59: 3498-3503.
5. Siddiqui. W. A., Tam. L. Q.. Kramer, K J.. Hui, G. S N., Case. S F. and Yamaga, K. M. et al. Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria. Proc. Natl Acad. Sci USA. 1987; 84: 3014-3018.
6. Daly, T.M and Long, C.A. A recombinant 15 kilodalton carboxyterminal fragment of Plasmodium voelii 17 XL merozoite surface protein I induces a protective immune response in mice. Infect Immun. 1993; 61: 2462-2467 .
7. Doolan, D., Sedegah, M., Hedstron, R.C., Hobart, P., Charoenvit. Y. and Hoffman. S.L. Circumventing genetic restriction of protection against malaria with multi-gene DNA immunisation: CD8+ T cell-. Interferon γ, and nitric oxide dependent immunity. J Exp. Med. 1996; 183: 1734-1746.
8. Becker, S.I., Wang R., Hedstrom, R.C., Agutar, J C., Jones T R. Hoffman S.L. and et al. Protection of mice against Plasmodium voelii sporozoite challenge with P.voelii merozoite surface protein I DNA vaccines, Infect. Immun. 1998; 66: 3457-3461.
9. Scherf, A., Mattei, D. and Sarthou, J L. Multiple infections and unusual distribution of block 2 of the MSA 1 gene of Plasmodium falciparum detected in West African clinical isolates by polymerase chain reaction analysis. Mol. Biochem. Parasit. 1991; 44: 297-300.
10. Miller, L.H., Robert, T., Shahabuddin, M. and McCutchan, T.F. Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein 1 (MSP-1). Mol. Buiochem. Parasitol. 1993; 59: 1-14.
11. 19) variants secreted from Saccharomyces cerevisae. Mol Biochem Parasitol. 1994; 63: 283-289.
12. Hui. G.S.N.. Hashiro, C., Nikaido, C., Case, S.E., Hashimoto, A., Gibson et al. Immunological cross-reactivity of the C-terminal 42-kilodalton fragment of Plasmodium falciparum merozoite surface protein 1 expressed in Baculovirus. Infect Immun. 1993; 61: 3403-3411.
13. Egan, A.F., Morris, J., Barnish, G., Allen, S., Greenwood, B.M., Kaslow, D.C. et al. Clinical immunity to Plasmodium falciparum is associated with serum antibodies to the 19 kDaC-terminal fragment of the merozoite surface antigen. PfMSP-1. J. Infect. Dis. 1996; 173: 765-769.
14. Riley, E.M. Allen, S.J., Willer, J.G., Blackmail, M.J., Bennett S. Takacs B. et al. Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (pf MSP 1) of Plasmodium falciparum are associated with reduced malaria mortality. Parasite Immunol. 1992; 14: 321-337.
15. Foley, M., Ranford-Cartwright, L.C. and Babiker, H A. Rapid and simple method for isolating malaria DNA from fingerprick samples of blood. Mol Biochem Parasitol. 1992; 53:241-244.
16. Kam, K.C. and Lanar, D.E.L. Determination of genetic variation within Plasmodium falciparum by using enzymatically amplified DNA from filter paper disks impregnated with whole blood. J. Clin. Macrobiol. 1991; 29: 1171-1174.
17. Kimura, M., Kaneko, O., Inoue, A., Ilshii, A. and Tanabe, K. Amplification by polymerase chain reaction of Plasmodium falciparum DNA from Giemsa-stained thin blood smears. Mol. Biochem. Parasit. 1995; 70: 191-197.
18. Egan, A.E., Chappel, J.A., Burghaus, P.A., Morris, S.M., McBride. J.S., Holder, A.A. et al. Serum antibodies from malaria-exposed people recognise conserved epilopes formed by the two epidermal growth factor motifs of MSPI 19, the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum. Infect. Immun. 1995; 63: 456-466.
19. Conway, D.J. Natural selection on polymorphic malaria antigens and the search for a vaccine. Parasit. Today. 1997; 13: 26-29.
20. Tanabe, K., Mackay, M., Goman, M. and Scaife, J.G. Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparum. J. Mol Biol. 1987; 195: 273-287.